Specifically, we observed a significant down-regulation of some of the most relevant genes in the PPAR pathway (CD36, FABP4, PLIN1, PLIN4, SCD5 and ACSL4) in tumor tissue samples. This evidence concerns the gene CD36 and neoplasm.